ArticleJournal of managed care & specialty pharmacy2026
Evaluating the feasibility of health care databases for assessing the safety of switching between originator biologics and biosimilars.
Aaron B Mendelsohn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.